IntegraGen Appoints Director for New Genetic Research Services
Paris, France, 25 October 2006 ... IntegraGen announced today the recent appointment of Emmanuel Martin as Director Sales and Marketing for its new business unit “Genetic Research Services”.
Customized high-throughput SNP genotyping services are provided to the research community to help accelerate discovery. IntegraGen offers access to the broadest technology portfolio in the market, including state-of-the art technologies such as SNPlex®, Agilent and Illumina®and IntegraChipsTM, superior BAC-arrays for genomic DNA applications.
Welcoming Emmanuel Martin in his new position, Dr Jan Mous, President and CEO of IntegraGen said: “Emmanuel has an outstanding track record and has already successfully brought in one major contract for genotyping. We are delighted to welcome him on board.”
Previously Mr. Martin worked at Applied Biosystems, Applera, France as a Senior Sales Specialist in SNP®genotyping and gene expression. In the eight years at Applied, he also worked as a business developer and research field engineer in Real Time PCR®.
In addition Mr. Martin has over 6 years of research experience in molecular biology. He qualified as a pharmacist and received his DEA “Bases Fondamentales de l’Oncogénèse” from the University of Paris V, France.
Commenting on his new role at IntegraGen, Mr. Martin added:
“IntegraGen is a very experienced company that can add a lot of value to other researchers. I am delighted to take the lead on the new business unit and I am looking forward to the challenge of developing this outstanding expertise of the Company.”
Mr. Martin will be based at IntegraGen’s offices in Evry, near Paris and will be responsible for promoting IntegraGen’s genotyping services and for client and distributors relations.
